Qritve CEO and Cofounder – Aneesh Sathe on InnovatorMD platform
As ChatGPT, Stable Diffusion, and other tools make news, healthcare is often asked how AI will make an impact. Qritive has been working on AI for histopathology since 2017. In healthcare and research, it is critical that AI provide inputs that are actionable, explainable, and trusted.
Qritive has recently closed its Series A and is rapidly expanding its operations. Qritive’s research has been published in leading journals and is backed up by strong clinical validations. Qritive now offers its products and services in the United States and is also seeking partners to help expand its operations.
